Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy

Intensive Care Medicine

Volumn 23, Issue 1, 1997, Pages 23-30

  Nolla Salas, J ^a   Sitges Serra, A ^b   Leon Gil C ^c   Martinez Gonzalez J ^d   Leon Regidor M A ^e   Ibanez Lucia P ^f   Torres Rodriguez J M ^g  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d PFIZER INC   (United States)

^e HOSPITAL GENERAL DE CATALUNYA   (Spain)

^f HOSPITAL LLUÍS ALCANYÍS   (Spain)

^g INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Amphotericin B; Antifungal therapy; APACHE II score; Candidemia; Critically ill patients; Fluconazole; Intensive care unit; Non neutropenic

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CRITICAL ILLNESS; FUNGUS CULTURE; HUMAN; INCIDENCE; INTENSIVE CARE; MAJOR CLINICAL STUDY; MORTALITY; PROBABILITY; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; APACHE; CANDIDIASIS; CRITICAL ILLNESS; CROSS INFECTION; DATA INTERPRETATION, STATISTICAL; FEMALE; FLUCONAZOLE; FUNGEMIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SPAIN;

EID: 0031035533     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050286     Document Type: Article

References (40)

1. Eubanks PJ, de Virgilio C, Klein S (1993) Candida sepsis in surgical patients. Am J Surg 166:617-620
2. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 15:414-421
3. Komshian SV, Uwaydah AK, Sobel JD, Crane LR (1989) Fungemia caused by Candida species annd Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Clin Infect Dis 11:379-390
4. Pfaller M, Wenzel P (1992) Impact of changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 11:287-291
5. Beck-Sagué CM, Jarvis WR, National Nosocomial Infections Surveillance System (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 167:1247-1251
6. Caroll K, Jeppson K, Reading J, Reimer L (1993) Factors influencing outcome in hospitalized patients with candidemia. Infect Dis Clin Pract 2:268-271
7. Roberts FJ, Geere IW, Coldman A (1991) A three-year study of positive blood cultures, with emphasis on prognosis. Clin Infect Dis 13:34-46
8. Wenzel RP, Pfaller MA (1991) Candida species: emerging hospital bloodstream pathogens. Infect control Hosp Epidemiol 12:523-524
9. Soutter DI, Todd TRJ (1986) Systemic candidiasis in a surgical intensive care unit. Can J Surg 29:197-199
10. Sobel JD (1988) Candida infections in the intensive care unit. Crit Care Clin 4:325-345
11. Walsh TJ, Hiemenz J, Pizzo PA (1994) Editorial response: evolving risk factors for invasive fungal infections - all neutropenic patients are not the same. Clin Infect Dis 18:793-798
12. Medoff G, Dismukes WE, Pappagianis D, Diamons R, Gallis HA, Drutz D (1992) Evaluation of new antifungal drugs for the treatment of systemic fungal infections. Clin Infect Dis 15 [Suppl 1]:S274-S281
13. Knauss WA, Draper EA, Wasner DP (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-822
14. Cullen DJ, Civetta JM, Briggs BA, Ferrara LC (1974) Therapeutic intervention scoring system. A method of quantitative comparison of patient care. Crit Care Med 2:57-60
15. Gosbell IB (1994) Central venous catheter-related sepsis: epidemiology, pathogenesis, diagnosis, treatment and prevention. Intensive Care World 11:54-58
16. Rex JH (1996) Editorial response. Catheters and candidemia. Clin Infect Dis 22:467-470
17. Dean DA, Burchard KW (1996) Fungal infection in surgical patients. Am J Surg 171:374-382
18. Ang BSP, Telenti A, King B, Steckelberg JM, Wilson WR (1993) Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis 17:662-666
19. Calandra T, Bille J, Schneider R, Mosimann F, Francioli P (1989) Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet II:1437-1439
20. Edwards JE Jr (1992) Editorial response: should all patients with candidemia be treated with antifungal agents? Clin Infect Dis 15:422-423
21. Armstrong D (1993) Treatment of opportunistic fungal infections. Clin Infect Dis 16:1-9
22. Perfect JR, Pickard WW, Hunt DL, Palmer B, Schell WA (1991) The use of amphotericin B in nosocomial fungal infection. Clin Infect Dis 13:474-479
23. Nolla-Salas J, León C, Torres-Rodríguez JM, Martín E, Sitges-Serra A (1992) Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clin Infect Dis 14:952-954
24. Milatovic D, Voss A (1992) Efficacy of fluconazole in the treatment of systemic fungal infections. Eur J Clin Microbiol Infect Dis 11:395-402
25. Ikemoto H (1989) A clinical study of fluconazole in the treatment of deep mycoses. Diagn Microbiol Infect Dis 12:239-247
26. Graninger W, Presteril E, Schneweiss B, Teleky B, Georgopoulos A (1993) Treatment of Candida albicans fungemia with fluconazole. J Infect 26:133-146
27. Rex JH, Bennett JE, Sugar AM (1994) A randomized study comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325-1330
28. Bodey GP (1992) Azole antifungal agents. Clin Infect Dis 14 [Suppl 1]: S161-S169
29. Galgiani JN (1990) Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies. Clin Infect Dis 12 [Suppl 3]:S272-S275
30. Kobayashi GS, Spitzer ED (1989) Testing of organisms of susceptibility to triazoles: is it justified? Eur J Clin Microbiol Infect Dis 8:387-389
31. Edwards JE Jr, Filler SG (1992) Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. Clin Infect Dis 14 [Suppl 1]:S106-S113
32. Hong Nguyen M, Peacock JE, Tanner DC, Morris AJ, Ly Nguyen M, Snydman DR, Wagener MM, Yu VL (1995) Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155:2429-2435
33. Harvey RL, Myers JP (1987) Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 147:2117-2120
34. Horn R, Wong B, Kiehn TE, Armstrong D (1985) Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Clin Infect Dis 7:646-655
35. Tang E, Tang G, Berne TV (1993) Prognostic indicators in fungemia of the surgical patient. Arch Surg 128:759-763
36. Dyess DL, Ganison RN, Fry DE (1985) Candida sepsis: implications of polymicrobial blood-borne infection. Arch Surg 120:345-348
37. Anonymous (1994) Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 20:522-528
38. Wenzel RP (1995) Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 20:1531-1534
39. Miller PJ, Wenzel RP (1987) Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis 156:471-477
40. Marshall JC, Christou NV, Meakins JL (1993) The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 218:111-119